Avatar for CHAIN Biotechnology

Live Biotherapeutic Product

Live Biotherapeutic Product

CHAIN Biotechnology is an exciting early-stage UK company developing human microbiome therapies, is seeking to raise additional seed capital. CHAIN’s patented production method and delivery platform technology is based on the unique exploitation of Clostridium bacteria, as a means to produce and deliver therapeutics to the gut targeting Inflammatory Bowel Disease– chronic, widespread and increasing ailments that currently have no satisfactory treatment. CHAIN is looking to close a £400K seed-round by end of November 2016, to be used to fund operations and to generate additional pre-clinical data (projects defined and partner clinicians already lined up), in preparation for a larger £3m A-round in mid-2017 to take the lead target product into clinical trials. The company which boasts a highly experienced scientific and management team, is EIS qualified, offering investors highly attractive tax incentives and has follow-on commitments from its existing angel investors.”

CHAIN Biotechnology hasn't added any jobs yet

Get notified when CHAIN Biotechnology posts new jobs.

See similar jobs
Founder CHAIN Biotechnology